Legault Pierre

CIK 000139104511 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001391045

Recent Transactions

50 trades

Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2026-02-04+24,000→ 114,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-02-05+25,000→ 90,000 total
Award
BICYCLE THERAPEUTICS PLC$BCYC
Ordinary Shares
2025-01-02+12,500→ 46,000 total
Award
BICYCLE THERAPEUTICS PLC$BCYC
Stock Option (right to buy)
2025-01-02+25,000→ 25,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2024-02-07+17,000→ 65,000 total
Award
BICYCLE THERAPEUTICS PLC$BCYC
Stock Option (right to buy)
2024-01-02+24,000→ 24,000 total
Award
BICYCLE THERAPEUTICS PLC$BCYC
Ordinary Shares
2024-01-02+12,000→ 33,500 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-02-02+16,000→ 48,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-01-13$13.58/sh+10,000→ 42,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-01-13$13.58/sh+5,000→ 37,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2023-01-13−5,000→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2023-01-13−10,000→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-01-13$27.00/sh−5,000→ 32,000 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-01-13$27.00/sh−10,000→ 32,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-01-12$9.47/sh+24,000→ 56,000 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-01-12$26.74/sh−24,000→ 32,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2023-01-12−24,000→ 0 total
Award
BICYCLE THERAPEUTICS PLC$BCYC
Stock Option (right to buy)
2023-01-03+23,000→ 23,000 total
Award
BICYCLE THERAPEUTICS PLC$BCYC
Ordinary Shares
2023-01-03+11,500→ 21,500 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-08-05$23.02/sh−14,000→ 32,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-08-05$8.93/sh+14,000→ 46,000 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-08-05$23.02/sh−10,000→ 32,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-08-05$9.63/sh+10,000→ 42,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-08-05−10,000→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-08-05−14,000→ 0 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-02-02+16,000→ 32,000 total
Award
BICYCLE THERAPEUTICS PLC$BCYC
Stock Option (right to buy)
2022-01-03+20,000→ 20,000 total
Award
BICYCLE THERAPEUTICS PLC$BCYC
Ordinary Shares
2022-01-03+10,000→ 10,000 total
Exercise/Conversion
BICYCLE THERAPEUTICS PLC$BCYC
Ordinary Shares
2021-12-22$8.48/sh+97,860→ 97,860 total
Exercise/Conversion
BICYCLE THERAPEUTICS PLC$BCYC
Stock Option (Right to Buy)
2021-12-22−97,860→ 23,312 total
Sale
BICYCLE THERAPEUTICS PLC$BCYC
Ordinary Shares
2021-12-22$58.01/sh−97,860→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-12-22$22.01/sh−24,000→ 16,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-12-22$7.88/sh+24,000→ 40,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2021-12-22−24,000→ 0 total
Exercise/Conversion
BICYCLE THERAPEUTICS PLC$BCYC
Stock Option (Right to Buy)
2021-12-21−44,537→ 121,172 total
Sale
BICYCLE THERAPEUTICS PLC$BCYC
Ordinary Shares
2021-12-21$57.11/sh−44,537→ 0 total
Exercise/Conversion
BICYCLE THERAPEUTICS PLC$BCYC
Ordinary Shares
2021-12-21$8.44/sh+44,537→ 44,537 total
Sale
BICYCLE THERAPEUTICS PLC$BCYC
Ordinary Shares
2021-12-20$57.02/sh−7,603→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-12-20$21.01/sh−20,000→ 16,000 total
Exercise/Conversion
BICYCLE THERAPEUTICS PLC$BCYC
Ordinary Shares
2021-12-20$8.41/sh+7,603→ 7,603 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2021-12-20−20,000→ 0 total
Exercise/Conversion
BICYCLE THERAPEUTICS PLC$BCYC
Stock Option (Right to Buy)
2021-12-20−7,603→ 165,709 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-12-20$7.08/sh+20,000→ 36,000 total
Exercise/Conversion
BICYCLE THERAPEUTICS PLC$BCYC
Stock Option (Right to Buy)
2021-04-08−24,838→ 173,312 total
Sale
BICYCLE THERAPEUTICS PLC$BCYC
Ordinary Shares
2021-04-08$32.13/sh−239→ 0 total
Sale
BICYCLE THERAPEUTICS PLC$BCYC
Ordinary Shares
2021-04-08$31.40/sh−12,099→ 239 total
Sale
BICYCLE THERAPEUTICS PLC$BCYC
Ordinary Shares
2021-04-08$32.00/sh−12,500→ 12,338 total
Exercise/Conversion
BICYCLE THERAPEUTICS PLC$BCYC
Ordinary Shares
2021-04-08$8.74/sh+24,838→ 24,838 total
Exercise/Conversion
BICYCLE THERAPEUTICS PLC$BCYC
Stock Option (Right to Buy)
2021-04-05−162→ 198,150 total
Sale
BICYCLE THERAPEUTICS PLC$BCYC
Ordinary Shares
2021-04-05$31.07/sh−162→ 0 total

Legault Pierre

Recent Transactions

Companies

Recent Filings

Address